Results 251 to 260 of about 5,666,730 (325)

RNA degradation by the exosome is promoted by a nuclear polyadenylation complex.

open access: yesCell, 2005
J. LaCava   +6 more
semanticscholar   +1 more source

Comprehensive In Vitro Profiling Demonstrates Successful Immune Evasion of Bioengineered Immune‐Shielded Heart Valves

open access: yesAdvanced Healthcare Materials, EarlyView.
Living donor heart valves offer superior durability for pediatric patients but trigger immune rejection. Lentiviral delivery of viral immune‐evasion genes US2 and Serpin b9 into donor valve cells and valve tissue suppresses HLA expression, reduces PBMC clustering and cytotoxic killing, and induces transcriptional immune‐tolerance programs, paving the ...
Abraham van Wijk   +11 more
wiley   +1 more source

Correction: A dedicated diribonuclease resolves a key bottleneck for the terminal step of RNA degradation.

open access: yesElife, 2022
Kim SK   +8 more
europepmc   +1 more source

Synergistic activation of Toll-like receptor 8 by two RNA degradation products

open access: yesNature Structural &Molecular Biology, 2015
M. Geyer, K. Pelka, E. Latz
semanticscholar   +1 more source

Near‐Infrared Light‐Activated Polydopamine Nanoparticles Conjugated With Transferrin Peptides for Enhanced Brain Accumulation

open access: yesAdvanced Healthcare Materials, EarlyView.
This study demonstrates that Tf‐PDA NPs combine a receptor‐mediated targeting with mild photothermal activation to enhance nanoparticle accumulation in the brain. NIR‐activated Tf‐PDA NPs increase BBB permeability to NPs in vitro and in vivo without inducing cytotoxicity or adverse immune responses.
Rafaela Ferrão   +5 more
wiley   +1 more source

Optimization of FFPE preparation and identification of gene attributes associated with RNA degradation. [PDF]

open access: yesNAR Genom Bioinform
Lin Y   +7 more
europepmc   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy